During the past decade, Szpital Powiatowy w Chrzanowie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Powiatowy w Chrzanowie" #1 collaborator was "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Royal Brompton & Harefield NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Szpital Powiatowy w Chrzanowie" are "Acute Coronary Syndrome" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Szpital Powiatowy w Chrzanowie" in a lesser frequency.

Most popular intervention types in "Szpital Powiatowy w Chrzanowie" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bivalirudin" (1 trials), "Coronary Angioplasty (PTCA)" (1 trials) and "Heparin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Szpital Powiatowy w Chrzanowie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Szpital Powiatowy w Chrzanowie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Szpital Powiatowy w Chrzanowie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Szpital Powiatowy w Chrzanowie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".